FiercePharma

Sandoz completes US offering of generic Lovenox® line with launch of enoxaparin sodium injection, USP vials

Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
FiercePharma

FDA Approves First Generic Enoxaparin Sodium Injection to Prevent DVT

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
Medscape

FDA Safety Labeling Changes: Lovenox, Nutropin Depot, Roferon-A

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Medscape

FDA Approves First Generic Enoxaparin Injection

July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...